Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENOXAPARIN Cause Product prescribing issue? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product prescribing issue have been filed in association with ENOXAPARIN (Enoxaparin Sodium). This represents 0.1% of all adverse event reports for ENOXAPARIN.

15
Reports of Product prescribing issue with ENOXAPARIN
0.1%
of all ENOXAPARIN reports
3
Deaths
2
Hospitalizations

How Dangerous Is Product prescribing issue From ENOXAPARIN?

Of the 15 reports, 3 (20.0%) resulted in death, 2 (13.3%) required hospitalization, and 3 (20.0%) were considered life-threatening.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENOXAPARIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does ENOXAPARIN Cause?

Off label use (1,707) Exposure during pregnancy (1,215) Haemorrhage (1,059) Foetal exposure during pregnancy (918) Anaemia (914) Thrombocytopenia (834) Dyspnoea (822) Maternal exposure during pregnancy (818) Drug ineffective (769) Nausea (708)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which ENOXAPARIN Alternatives Have Lower Product prescribing issue Risk?

ENOXAPARIN vs ENOXAPARIN - WINTHROP ENOXAPARIN vs ENSIFENTRINE ENOXAPARIN vs ENTACAPONE ENOXAPARIN vs ENTECAVIR ENOXAPARIN vs ENTINOSTAT

Related Pages

ENOXAPARIN Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue ENOXAPARIN Demographics